Pathstone Holdings’s Incyte INCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.25M Buy
10,921
+928
+9% +$92K ﹤0.01% 1395
2026
Q1
$941K Buy
9,993
+73
+0.7% +$7.28K ﹤0.01% 1443
2025
Q4
$980K Sell
9,920
-298
-3% -$28.8K ﹤0.01% 1424
2025
Q3
$867K Buy
10,218
+281
+3% +$22.2K ﹤0.01% 1503
2025
Q2
$677K Buy
9,937
+22
+0.2% +$1.39K ﹤0.01% 1578
2025
Q1
$601K Sell
9,915
-634
-6% -$44.2K ﹤0.01% 1628
2024
Q4
$729K Buy
10,549
+1,042
+11% +$74.2K ﹤0.01% 1535
2024
Q3
$628K Buy
9,507
+166
+2% +$10.6K ﹤0.01% 1622
2024
Q2
$566K Buy
9,341
+2,516
+37% +$142K ﹤0.01% 1622
2024
Q1
$389K Buy
6,825
+1,137
+20% +$68.2K ﹤0.01% 1802
2023
Q4
$357K Buy
+5,688
New +$322K ﹤0.01% 1711

Other funds holding INCY

Pathstone Holdings's INCY Position: Q2 2026 in Review

Pathstone Holdings increased its Incyte (INCY) stake by 9.3% in Q2 2026, buying an estimated $92K and bringing the position to 10,921 shares worth $1.25M. The position accounts for ﹤0.01% of the portfolio, ranked #1395.

Pathstone Holdings first reported a position in INCY in Q4 2023 and has held it in 11 quarters since. 855 funds tracked by Wall St. Rank hold INCY as of Q2 2026.

  • Pathstone Holdings held 10,921 shares of Incyte worth $1.25M as of Q2 2026.
  • Pathstone Holdings bought 928 Incyte shares in Q2 2026, an estimated $92K.
  • Incyte made up ﹤0.01% of Pathstone Holdings's portfolio in Q2 2026, its #1395 holding.
  • Pathstone Holdings first reported a position in Incyte in Q4 2023 and has held it in 11 quarters since.
  • 855 funds tracked by Wall St. Rank held Incyte as of Q2 2026.

Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.